We are live on ! Find out more

10 hedge funds and large institutions have $2.71M invested in cbdMD in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

190% more capital invested

Capital invested by funds: $936K → $2.71M (+$1.78M)

100% more funds holding

Funds holding: 510 (+5)

0% more ownership

Funds ownership: 0.01%0.01% (+0%)

Holders
10
Holders Change
+5
Holders Change %
+100%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

YCBD Hedge Fund Activity: Q4 2018 in Review

10 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in cbdMD (YCBD) for Q4 2018, worth a combined $2.71M — up 190% from $936K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new YCBD positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, adding an estimated $1.25M. The largest seller was Deutsche Bank, exiting entirely with an estimated $11K sold.

  • 10 institutional investors held cbdMD (YCBD) as of Q4 2018, up from 5 in Q3 2018.
  • Funds reported $2.71M of cbdMD stock for Q4 2018, up 190% quarter-over-quarter.
  • 7 funds opened new cbdMD positions in Q4 2018 and 2 closed out, a net change of +5 holders.
  • The largest cbdMD buyer in Q4 2018 was BlackRock, an estimated $1.25M added.
  • The largest cbdMD seller in Q4 2018 was Deutsche Bank, an estimated $11K sold.

Based on aggregated 13F filings for Q4 2018.